Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gretel Terrero"'
Autor:
Albert C. Lockhart, Andrea Wang-Gillam, Michael J. Naughton, Joel Picus, Rama Suresh, Feng Gao, Gretel Terrero, Maria Q. Baggstrom, Lauren Trull, Cynthia Ma, Paula M. Fracasso, Benjamin R. Tan, Manik Amin, Stephanie Belanger
Publikováno v:
American Journal of Clinical Oncology. 44:443-448
Introduction The mammalian target of rapamycin (mTOR) is a downstream mediator in the phosphatidylinositol 3-kinase/Akt signaling pathway, and plays a central role in cell proliferation, growth, differentiation, migration, and survival. Temsirolimus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ab48ae4bb924e299f925b84d3b4194c
https://doi.org/10.1097/coc.0000000000000852
https://doi.org/10.1097/coc.0000000000000852
Autor:
A. Craig Lockhart, Gretel Terrero
Publikováno v:
Current oncology reports. 22(11)
Immunotherapy and tumor microenvironment have been at the forefront of cancer research over the past several decades. Here, we will review the role of immunotherapy in advanced gastroesophageal cancers including targeted antibodies, immunomodulating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be8ba0cbd0fd0b75b71483268255092c
https://pubmed.ncbi.nlm.nih.gov/32803457
https://pubmed.ncbi.nlm.nih.gov/32803457
Publikováno v:
Journal of Clinical Oncology. 38:754-754
754 Background: Immune checkpoint inhibitors (ICI’s) have not shown meaningful clinical activity in unselected pts with PDAC. BRCA-deficient tumors have increased genomic instability, including increased tumor mutation burden (TMB), more tumor-infi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cae37ba169cfa4b577580b62efbe156
https://doi.org/10.1200/jco.2020.38.4_suppl.754
https://doi.org/10.1200/jco.2020.38.4_suppl.754
Autor:
Gretel Terrero, Manisha Jayandra Patel, Caio Max Sao Pedro Rocha Lima, Sameeha Rau, Peter J. Hosein, Andrea P. Espejo Freire, Benjamin Woodress Rush
Publikováno v:
Journal of Clinical Oncology. 38:731-731
731 Background: Chemotherapy is the standard of care for patients with mPDAC but there are no biomarkers to aid in treatment selection. Nal-IRI with 5-fluorouracil/folinic acid (FUFA) improves survival over FUFA in the second-line treatment of mPDAC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d70c2cb946bcfc23e8b0c283bcdfae9
https://doi.org/10.1200/jco.2020.38.4_suppl.731
https://doi.org/10.1200/jco.2020.38.4_suppl.731
Autor:
Ronald A. Cohen, Athena Poppas, Michael L. Alosco, John Gunstad, Gretel Terrero, Lawrence H. Sweet, Donald R. Labbe, Uraina S. Clark, Hannah Riskin-Jones, Edward G. Walsh, Xiaomeng Xu, Nicolette F. Schwarz
Publikováno v:
Journal of the American Society of Hypertension. 8:561-570
Hypertension may increase risk for dementia possibly because of its association with decreased cortical thickness. Disturbed cerebral autoregulation is one plausible mechanism by which hypertension impacts the cerebral structure, but the associations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ecefb3367247fa56299539681a8b66f
https://doi.org/10.1016/j.jash.2014.04.002
https://doi.org/10.1016/j.jash.2014.04.002
Publikováno v:
Molecular Reproduction and Development. 78:Fm i-Fm i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::491f361e8e9c042244175801e26930d7
https://doi.org/10.1002/mrd.21322
https://doi.org/10.1002/mrd.21322